BioAge Stock Dropped Before June Investor Call on Key Drug
New York, May 22, 2026, 4:02 PM EDT BioAge Labs shares ended lower Friday, giving up 0.8% to close at $16.61. The move trailed the Nasdaq Composite, which Reuters said was up 0.5% in the afternoon. The clinical-stage biotech set new investor meetings for June but didn’t provide clinical updates.